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Abstract 
Peri-operative environments are a hazardous setting for diabetes patients. A systematic review of literature regarding the management of diabetes 
patients across the peri-operative pathway has been undertaken to assess if the management of patients within this pathway is suitable and effective 
for patients.
Methods
A database search of Google Scholar, CINAHAL, Embase, OVID, Cochrane Library, Joanna Briggs institute and PUBMED was undertaken from 15th 
of March 2019 to 30th of March 2019. A total of 57 papers were found and reduced down to 11 final papers that answered the review question and met 
the inclusion and exclusion criteria. Inclusion criteria were: Full text, English language, human subjects, adult patients only and studies that focused 
on diabetes care in a section of the peri-operative pathway. Exclusion criteria: children or adults and children, studies that looked a one particular 
intervention or type of surgery. No date limit was set. PICO tool was used to frame the study question.
Results 
Three main themes emerged from the literature. 1. Poor patient outcomes; 2. Longer length of stay (LOS); 3. Lack of adherence to guidance and or 
protocols and glycaemic control. Elective patients had advantageous outcomes compared to emergency surgical patients. Hyperglycaemia still 
remained a problem with an increase in other medical complications for diabetes patients. LOS in hospital was found to have increased due to medical 
complications. Adherence to protocols and guidance was found to be beneficial in monitoring and managing hyperglycaemia. However, this review 
found that best practice guidance and hospital protocol is not always adhered to. A liberal approach to glycaemic control is beneficial. 
Conclusion 
This systematic review investigated the management of diabetes patients across the peri-operative pathway. Three main themes emerged from the 
literature: poor patient outcomes; length of stay; and lack of adherence to guidance and or protocols and glycaemic control. We concluded the peri-
operative environment is a hazardous setting for a diabetes patients. Elective patients had slightly more advantageous outcomes than emergency 
patients. Hyperglycaemia still remains a problem which leads to poor patient outcomes and longer LOS. Adherence to protocols and guidance was 
found to be beneficial in monitoring and managing hyperglycaemia. 
Introduction 
The Department of Health and Social Care (DOH) (2001) state 
that diabetes patients undergoing surgery carry a greater clinical risk 
than non-diabetes patients. This is due a number of complex factors 
such as reduced food intake due to a starvation period, and cessation 
of normal diabetes medications [1]. In addition, the body’s stress 
response and inhibition of insulin secretion increases the potential for 
hyperglycaemia [2]. The Association of Anaesthetists of Great Britain 
and Ireland [3] state that diabetes affects 10–15% of the surgical 
population, with these patients carrying a greater risk of complication 
rates, mortality rates and Length of stay (LOS). 
Despite these findings, there is very little guidance and research 
surrounding diabetes management across the peri-operative pathway. 
There are currently no standardised worldwide guidelines for use by 
theatre or PACU practitioners [4] and globally, diabetes management 
during the peri-operative period is widely debated [5]. The aim of 
this systematic review was to investigate the management of diabetes 
patients across the peri-operative pathway. 
Methodology
A systematic and comprehensive search of databases was carried 
out between the 15th of March 2019 and the 30th of July 2019. The 
search involved Google Scholar, CINAHAL, Embase, OVID, Cochrane 
Library, Joanna Briggs institute and PUBMED. Combinations of 
key words were inputted into each database. Further restrictions 
were then applied to reduce the number of papers, such as; English 
language, full text and used adult human patients as the participants. 
Studies which examined the care and management of diabetes patients 
across the peri-operative pathway were included. Studies into specific 
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interventions or surgeries were excluded due to the broadness of the 
review question. Exclusion criteria: children participants and studies 
that looked a one particular intervention or type of surgery. No date 
limit was set. 
This review followed the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines to ensure systematic 
transparency of report [6]. After duplications were removed, 57 papers 
were read to determine their relevance to the review question.
Figure 1. PRISMA flow diagram of Studies included in quantitative synthesis
The Cauldwell, Henshaw and Taylor (2011)  framework was 
utilised for assessing the meaningfulness or generalisability of 
qualitative and quantitative research in contemporary nursing 
practice, which enabled a structured approach to the assessment of 
each study’s quality, validity and reliability (Clarke, 2011). The final 11 
papers were RAG (red amber green) rated [7] to reflect the answer to 
each of the questions from the tool. Dates ranged from 1983- 2019 and 
included studies from various countries. 9 of the 11 studies focused 
on the peri-operative period. 1 study focused on intra-operative 
and post-operative diabetes management. 1 study looks at diabetes 
management in the pre-operative period. Full text was then read to 
extract the results from each paper for the formation of themes. 
Results and discussion 
A systematic review as undertaken to establish the management of 
diabetes patients across the peri-operative pathway. Three key themes 
emerged from the review: poor patient outcomes, length of stay (LOS) 
which were commonly reported jointly and adherence to guidance 
and or protocols and standards for glycaemic control.
Poor patient outcomes
8 out of 11 studies reported on the outcomes of patients with 
diabetes. Studies 2, 3,5,6,8,9,10 and 11 discussed surgical outcomes 
directly related to diabetes management. McCavert, Monem and 
Dooher, et al [8] found that best practice of glycaemic control, in-
line with hospital protocols, saw a 25.4% reduction of peri-operative 
complications. Overall complications being 29% (out of 69 patients). 
Elective patients with T2DM were more prone to complications. 5 out 
of 17 (29.4%) of T2DM elective patients experienced complications; 
in contrast, only 4 out of 21 (19.0%) of elective patients with T1DM 
developed a complication such as wound infection or peritonitis. 
For emergency patients, the rate of complications was slightly higher 
for those with T1DM (5 out of 14; 35.7%) versus 6 out of 17 patients 
(35.3%) with T2DM. Complications such as; Wound dehiscence, 
septicaemia, wound infection, wound infection, confusion, deep vein 
thrombosis and lower respiratory tract infection were reported as a 
complication. Frisch, Chandra, Smiley, et al [9] similarly analysed 
outcomes of mobility contrasting both diabetes and non-diabetes 
patients. Outcomes such as pneumonia (12.1 vs 5.4%; p=0.001), wound 
and skin infections (5 vs 2.3%; p<0.001), systematic blood infection 
(3.6 vs 1.1%; p<0.001), urinary tract infections (4.5vs 1.4%, p<0.001) 
acute myocardial infarction (2.6 vs 1.2 %; p< 0.001) were reported. 
Patients who experienced complications had a strong affiliation with 
high blood glucose levels pre and post-operatively. 
“Haemoglobin A1c, often abbreviated as A1C, is a form of 
haemoglobin (a blood pigment that carries oxygen) that is bound to 
glucose” [10]. Underwood, Askari, Hurwitz et al [11] linked to various 
A1C categories to patient outcomes. It showed that, like McCavert 
et al and Frisch et al, [8, 9] diabetes patients (specifically group A1C 
≤6.5%) had a higher incidence of LOS, acute renal failure death 
within 30 days and wound class (dirty). Groups ≤6.5%, A1C> 8-10% 
and A1C > 10% was significantly longer compared with the control 
subjects (p<0.001,p<0.008, and p=0.002, respectively).
Wang, Chen, Li, et al (2019) found that patients over 65-years 
old, male, high mean post-operative blood glucose (BG), diabetes 
complications, abnormal kidney function and have underwent 
general surgery were the highest risk category for poor patient 
outcomes. The study compared surgery type and patient outcomes. 
Of the 301 (19.8%) of all patients with diabetes complications, 295, 
(98.0%) had major vascular complications, 8 (27. %) had diabetes 
nephropathy, 3 (0.7%) had diabetes retinopathy, 5 (1.7%) had diabetes 
foot post-operatively. Post-operative adverse events occurred in 
118 (7.7%) including 43 (36.4%) delayed extubation caused by 
surgery-related respiratory failure or muscle weakness. 15 (12.7%) 
patients had circulatory disorders, 23 (19.5%) had respiratory and 
circulatory abnormalities. 11 (9.3%) had non-healing of the incision. 
15 (12.7%) had infections at other sites. 8 (6.8%) patients with other 
complications. 3 (2.5%) patients died due to pulmonary embolism and 
two cases of septic shock. Kotgal, Symods, Hirsch, lrl, et al [12] did not 
correlate BG management with patient outcomes, but results showed 
that patients had a greater chance of poorer outcomes with any level of 
hyperglycaemia versus those who had better diabetes control. 
In contrast, Sathya, Davis, Taveria, et al [13] found that stroke, 
atrial fibrillation and wound infection were the most significant 
complications from pooled results of 6 studies. Mixed results were 
noted; 2 pooled results found that the incidence of post-operative 
stroke was reduced by liberal glycaemic regimes, but pooled results 
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from a further 3 studies suggested that there was no significant 
difference between the effect of moderate vs strict control on stroke 
outcomes (odds ratio, 18.5, 95% CI 0.72-4.74, p=0.020). Sathya et al 
[13] also examined the relationship between atrial fibrillation as a 
patient outcome and diabetes control. Again, pooled estimates from 
2 pooled studies found that moderate versus liberal control had no 
direct effect on atrial fibrillation as an outcome (Odds ratio 0.54, 95% 
CI 0.17-1.76, p =0.31). In addition, pooled results from 3 other studies 
found that there was no significant difference between strict versus 
moderate control in relation to atrial fibrillation (odds ratio: 0.71, 95% 
CI0.39-1.30, p=0.27). Wound infection was also not found to have a 
significant link to the effects of moderate versus glycaemic control 
from the results of 2 pooled studies. 
Length of stay 
LOS was a significant finding in studies 2, 3, 6 and 8. Although not 
a complication in itself, LOS was linked to or reported alongside poor 
patient outcomes. 
McCavert et al [8] found that Emergency patients had a 
significantly longer LOS in hospital than the elective groups. Frisch 
et al (2010) [9] also reports that diabetes patients had a higher rate 
of complications than non-diabetes counterparts (p=0.105). Patients 
with diabetes were found to have a greater LOS (and LOS in ICU) 
than non- diabetes patients. It was also noted that African American 
patients were not at an increased risk of mortality than other races. No 
other study compared likelihood of surgical outcomes and race. 
Patients with diabetes were also more likely to have greater 
complications including LOS. Underwood et al, 2014 [11] however, 
reported that patients with A1C levels >6.5-8% had a similar LOS to 
the control group. Patients with higher A1C ≤6.5 up to greater than 
10% had a significantly longer LOS compared to control subjects. 
This was the most significant difference of the various A1C groups 
compared in the study. Higher A1C level was more significant than 
any other variable such as a diabetes patient’s race, gender or type 
of surgery in relation to LOS. Longer LOS in the hospital was found 
by Hommel et al [14] to be associated with higher dissatisfaction of 
patients regarding patient centred-ness in their assessment of results.
Lack of adherence to guidance and or protocols and 
glycaemic control 
The third key theme that emerged from the literature was 
adherence to guidance, such as hospital protocols and national 
guidelines and glycaemic control. This theme was disused in studies 
1,2,5,7 and 10. 
McCavert et al [8] studied both elective and emergency surgical 
patients. 60% of elective patients with T1DM were not treated 
according to hospital protocol. Elective patients who were treated 
according to protocol had a complication rate of 6.3 %. For emergency 
surgical patients, 7.3% of T1DM patients who were treated as per 
protocol developed a complication. 12.3% of scheduled blood glucose 
measurement were not completed. 11.1% of T1DM elective patients 
did not have their blood glucose checked, and 6.8% of emergency 
T1DM patients. For T2DM, blood glucose was not checked in 17.4% 
of elective patients and 12.7% in emergency cases.
Similarly, Coan, Schlinkert, Brandon et al [15] note that capillary 
BG was taken in 89% of cases in the pre-operative area, and only52% 
of patients had a HBA1C. Intra-operatively, 33% of patients had 
a BG check, and the post- operative figure was 87%. 90% of pre-
operative BG was point of care (POC), and 4% was venous sampling. 
Intraoperatively, 10% of patients had POC BG values, 16% had POC 
blood gas sampling. In the PACU, 86% of BG were obtained by POC 
and 1% was venous. Similarly, Jackson, Patvardhan et al (2015) 
reported that only 71% of patients had a HBA1C recorded pre-
operatively and 56% intra-operatively via CBG. 73% of patients had 
a CBG performed in recovery (PACU) contrary to national guidance. 
Hommel, Van Gurp, Tack et al’s [16] quality indicators suggest that 
best-practice involved measuring BG 4 hours pre-operatively, every 
2 hours intra-operatively, and 1 hour post-operatively. Hommel et 
al [14] reported that in relation to patient satisfaction and person 
centeredness, 20% of 362 patients were not informed about intra-
operative BG level and its effect. 15% were also not informed that 
insulin was administered during surgery. This correlated to overall 
low score from patients’ involvement in the survey. Sathya et al 
[13] report that patients undergoing a liberal target for glycaemic 
control had significantly better post-operative outcomes (less or no 
complications) than other groups. No difference with wound infection 
or atrial fibrillation were found. Bibble (1983) commented from the 
3 case studies that protocols for glycaemic control were directed 
towards managing ‘average’ diabetes patients rather than complex 
ones, making guidance non-beneficial.
Future recommendations would be to undertake extensive 
quantitative and qualitative research across the peri-operative 
pathway with staff who have direct responsibility for diabetes patients 
undergoing surgery. The views and attitudes of staff members 
regarding diabetes management may shed light on the barriers as to 
why this is still a problem despite being highlighted by several studies 
seen in this review since 1983. Any further research conducted needs 
to be influential on practice in order to drive change.
Conclusion 
This systematic review examined the management of diabetes 
patients across the peri-operative pathway. Three main themes 
emerged: poor patient outcomes; longer length of stay; and lack of 
adherence to guidance and or protocols and glycaemic control. We 
concluded the peri-operative environment can be a hazardous setting 
for diabetes patients. Elective patients had slightly more advantageous 
outcomes than emergency patients. Hyperglycaemia still remains 
a problem which leads to poor patient outcomes and longer LOS. 
Adherence to protocols and guidance was found to be beneficial in 
monitoring and managing hyperglycaemia. 
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Table 1. Characteristics of studies
Study No Title Author/s Year Type of study Participants Location/
setting
Findings/results/statistics
1. Perioperative 
control of 
diabetes 
mellitus – 
revisited 
Bibble C.J 
Hernandez, S
1983 Case reports 3 case studies of 
diabetes patients 
undergoing surgery. 
Adult patients. 
America 
theatre setting 
- Maryland
Case 1 arrived to the operating room confused 
distressed and complaining of a headache. The 
morning of surgery she was given 5 units of 
regular insulin and 5 % dextrose in physiolic 
saline. Blood glucose of the patient was 66mg/
dl. The patient experienced ‘wide swings’ 
in blood glucose levels intraoperative and 
postoperatively. 
Case 2 have 75-year-old male with Multisystem 
disease such as heart failure. His normal regime 
was 15 units in the morning and 15 units in the 
evening. 10 units was given subcutaneously 
to the patient on the morning of surgery. 
Blood glucose was 58mg/dl. Intervention raise 
the blood glucose to 211mg/dl. The patient 
experienced wide ranges of blood glucose for 
the next 8 days.
Case was a 39-year-old male with juvenile 
onset diabetes of 19 years. The patient had 
a strict diet and 15-25 units of lente insulin 
every morning. The morning of surgery 10 
units of insulin was given subcutaneously and 
intravenous dextrose 5% in lactated ringers 
solution was started at 155 cc per hour. The 
patient didn’t arrive to the operating room until 
4 hours later with a blood glucose level of 
420mg/dl. 
All patients experienced wide swings in glucose 
levels which could have been avoided. 
2. Peri-operative 
blood glucose 
management in 
general surgery 
– a potential 
element for 
improved 
diabetes patient 
outcomes- an 
observational 
cohort study 
McCavert , M., 
Monem, F., Dooher, 
M ., Brown, R and 
O’Donnell, M.E. 
2010 Observational 
cohort study. 
Data collected 
was regarding 
blood glucose 
measurements, 
adherence 
to the 
protocol and 
complications 
following 
surgery.  
69 patients. 
Males=44. 
Females=25. 
Median ages 61. 
35= type 1. 34=type 
2. 38 underwent 
elective surgery, 
31 underwent 
emergency surgery. 
Elective males 
=29, females, 
9, emergencies, 
males=15 and 
females =16.  
Daisy hill 
hospital 271 
bed DGH 
located in 
Newry City 
Northern 
Ireland. 
10.3% of CBG capillary blood glucose 
readings. were less than 6.1mmol\l, 32.8% 
were between 6.1mmol and 10.0mmol/l, 
44.6% were greater than 10.0mmol/l . 12.3% 
of scheduled blood glucose measurements 
were not completed. Insulin dextrose infusion 
was indicated in 30 patients. Of which 24 
(46.7%) were treated according to protocol. 
In 16 protocol deviated cases, insulin was 
administered as a sliding scale, 6 patients.  14 
35.9% were inappropriately given insulin. 
Only 39 (56.5% of patients) were treated as per 
protocol. Overall complication rate was 29.4% 
which included 7 out of 39% 17.6% and 13 out 
of the 30 43.3% protocol based and protocol 
deviation patients retrospectively. P=0.45.
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Study No Title Author/s Year Type of study Participants Location/
setting
Findings/results/statistics
For elective surgery time points patients 
within blood glucose groups were <6.1mmol/
l=1(7.4%)6.1-10.0mmol/l =3.5 (25.9%), 
>10mmol/l =7.5 (55.6%), not checked was 
=1.5 (11.1%) for Type one diabetes melitus 
(T1DM) (n=21) and <6.1mmol/l =0.75 (6.5%), 
6.1-10.0mmol/l =4.5 (39.1%), >10.0mmol/l 
=4.25 (37%), not checked =2 (17.4%) for type 
2 diabetes melitus T2DM (n=17) patients. 
For emergency patients , time points , the 
proportions of patients within each BG groups 
were ; 6.1 =0.5 (4.5%) , 6.1-10.0 mmol/l =2.5 
(22.7%), >10.ommmol/l =7.25 (65.9%), not 
checked =0.75 (6.8%) for T1DM (n=14) and 
<6.1mmol/l =3.75 (23.8%), 6.1-10.0mmol/l 
=6.25 (39.7%) ,> 10.mmol/l=3.75 (23.8%), not 
checked = 2(12.7%) for T2DM (n=17).
Comparisions of blood glucose level at 
different time points.  6 am day 0= 93%, 6pm 
day 0 88.3%, 6am day 1 85.7%, 6am day 2 
80.6%. At each time point the proportion of 
total admitted patients that had blood glucose 
BG, 6.0 mmol/l was 6am day 0=12.3% 6pm 
day 0= 10%, 6am day 1 =10.7% , 6am day 2  
6.4% between 6 and 10 mmol/l was 6am day 0 
=33.3% , 6pm day 0= 30% 6am day 1 = 30.4%, 
6am day 2 =41.9% and >10mmol/l was; 6am 
day=0 47.4% , 6pm day 0 =48.3% 6am day 1 
=44.6% 6am D2=32.3%. 
A GILK infusion was indicated in 30 patients 
(43.5%) according to hospital – based protocol 
(elective T1DM = 14, elective T2DM=3, 
emergency T1DM=6, emergency T2DM 
=7). 14 (46.7%) of these patients had a GIK 
infusion erected during the peri-operative 
period (elective T1DM =3, emergency T2DM 
=0). 6 of the 16 patients who did not receive 
GIK infusion according to protocol were 
managed with an insulin sliding scale.  one of 
the remaining patients was treated with a peri-
operative bolus of insulin. No specific stagey 
followed up the other 9 patients. 
25.4% reduction of peri-operative 
complications overall complications being 
29% (out of 69 patients). Elective patients with 
T2DM were more prone to complications. 5 
out of 17 (29.4%) of T2DM elective patients 
experienced complications; in contrast, only 
4 out of 21 (19.0%) of elective patients with 
T1DM developed a complication such as 
wound infection or peritonitis. For emergency 
patients, the rate of complications was slightly 
higher for those with T1DM (5 out of 14; 
35.7%) versus 6 out of 17 patients (35.3%) with 
T2DM.
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Study No Title Author/s Year Type of study Participants Location/
setting
Findings/results/statistics
3. Prevalence 
and clinical 
outcome of 
hyperglycaemia 
in the 
perioperative 
period in non-
cardiac surgery 
Frisch, A., Chandra, 
P., Smiley , D., 
Peng, L., Rizzo, 
M.,Gatcliffe,C., 
Hudson,M., 
Mendoza, J., 
Johnson,R., Lin,E 
and Umpierrez, G.E. 
2010 Observational 
study regarding 
pre and post 
glucose 
levels and 
the hospital 
length of stay, 
complications 
and mortality 
in 3,184 
noncardiac 
surgery 
patients. 
3,184. 53.8% 
female and 46.2%. 
Mean age ±SD age 
56.5±16nyears and 
BMI 27.6 ±7.3kg/m2 
 
Emory 
University 
Hospital 
Atlanta 
Georgia. 
Data collected from 1st of Jan 2007 to the 30th 
of June 2007. Patients were split into diabetess 
and non-diabetess. 643 (20.2%) patients has 
a known history of diabetes. Patients with 
diabetes compared to patients without diabetes 
(61.2±13.2 vs 55.4 ±15.9 years <0.001), had 
had higher BMI (29.6 ±7.8 vs. 26.8± 6.9 kg/
m2 p<0.001), were more likely to be male, 
(52.1 vs 44.8%; p<0.001), were of minority 
ethnic groups (African Americans 28.8 vs 
21.4%;p<0.001), and were more likely to 
undergo high-risk surgical procedures (8.9 vs 
6%; p<0.012). Blood glucose BG for the cohort 
was 120 ±38 mg/dl. Non diabetes patients had 
a lower pre-surgery blood glucose BG levels 
(113±28mg/l) than patients with diabetes (145 
± 51 mg/l; p<0.001). BG level on the first day 
after surgery was 155±42 mg/l in diabetes 
patients and 132± 28mg/dl) both results were 
higher that reported during subsequent hospital 
stays; (139±34 and 115± 21mg/dl p<0.001). 
Post-surgery 40% of patients had mean blood 
glucose >140mg/dl. Three fourths of these had 
mean BG between 141 and 180mg/dl, the other 
had >180 mg/dl. The study defined clinically 
significant hyperglycaemia as >180mg/dl. 7.9% 
had this before surgery, 17.2% had this on the 
day of surgery and in 9.9% during the post-
operative period. 
For non-diabetes’s mortality rate was 2.3% (72 
of 3112). 3.1% for diabetess and 2.1% for non-
diabetess. Did not reach statistical significance 
(p=0.0105). Diabetes patients had higher rate 
of complications including pneumonia (12.1 vs 
5.4%; p=0.001). Wound and skin infections, (5 
vs 2.3%; p=0.001), systematic blood infections 
(3.6 vs 1.1%;p=0.001), urinary tract infections 
(4.5 vs1.4% ;p<0.001), acute myocardial 
infarction (2.6 vs 1.2%;p=0.008) and ARF (9.6 
vs 4.8%; p=0.001). Diabetess had a higher 
length of stay and ITU length of stay than non-
diabetes subjects (8.8± 10.6 vs 7±10.8 days; 
p=0.001 and 2.3± 6.2 vs 1.8 ±6.5 days; p<0.01). 
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Study No Title Author/s Year Type of study Participants Location/
setting
Findings/results/statistics
Multi variant adjustment was made for age, 
sex, race and surgery severity showed that 
preoperative glucose can be a predictor of 
mortality with marginal significance (p=0.063) 
and likewise post-operative blood concentration 
(p=0.087).  African American patients did 
not have an increased risk of morbidity 
(p=0.96) but they were more likely to develop 
pneumonia (p=0.0075) and ARF (p=0.0158) 
than non- African-Americans. No significant 
different between racial groups after surgery. 
Patients who died had a significantly higher 
blood glucose before surgery (133.4± 40.9 vs 
119.9 ±37.7mg/dl;p=0.002) and after surgery 
(126.6± 23.7vs 119.7±26.6 mg/dl; p<0.001). 
Majority were men (p<0.001) they had longer 
hospital day (18±24vs 7±10 days; p<0.001) 
and had higher rates of ARF (30.6 vs 5.2%; 
p<0.001) and bacteraemia/ sepsis (16.7 vs 
2.2%; p<0.01). 
4. Intensity of 
peri-operative 
glycaemic 
control and 
postoperative 
outcomes in 
patients with 
diabetes: a 
meta-analysis. 
Sathya, B., Davis, 
R., Taveria, T., 
Whitlach,H and Wu, 
W.C.
2013 Meta –
Analysis 
relating to the 
role of specific 
glycaemic 
targets of 
diabetes 
patients 
relating 
postoperative 
outcomes. A 
systematic 
review was 
performed by 
two authors. 
0 participants. Not stated. 
USA stated 
as the authors 
places of work. 
Literature searches yielded 754 citations. 
681 were excluded based on a review of 
their abstracts and 3 studies were added 
from screening of reference lists of papers. 
76 underwent full text review with 42 being 
excluded due to absence of a control group. 
15 were excluded due to lack of outcome data. 
9 excluded due to absence of post-operative 
adverse event data. 6 studies were included in 
the meta-analysis. 
One was a non-randomized prospective study 
of 200 patients, three were randomized trials of 
423 patients. Five out of six studies included 
exclusively patients with diabetes. One study 
had patients with diagnosed diabetes and 
undiagnosed diabetes who mainly met criteria 
for having diabetes.  Glycaemic targets varied 
between trials. Four trails compared liberal vs 
moderate glycaemic control. 
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Study No Title Author/s Year Type of study Participants Location/
setting
Findings/results/statistics
150 deaths occurred. 74 in the liberal control 
group and 69 in the moderate control group. 
7 in the strict control group. Pooled results 
suggested that a moderate glycaemic control 
strategy was linked with significant reduction 
in mortality vs a liberal control. (odds 
ratio =0.48, 95% CI 0.24-0.76, p=0.004). 
Heterogeneity found in the pooled estimates 
(I2=20.7%, p=0.29). Beggs test publication 
bias (p=0.01). Pooled results did not show 
significant difference between moderate vs 
strict glycaemic control (odds ratio =0.94, 95% 
CI: 0. 40-2.19, p=0.88 )2 studies compared 
moderate vs liberal with significant reduction 
in the incidence of stroke (odd ratio 0.61, 95% 
CI 0.38-0.98, p=0.04). Without significant 
heterogeneity (I2=0% p=0.68). Pooled 
results from 3 studies showed no significant 
difference between the effect of moderate vs 
strict glycaemic control (odds ratio 1.85, 95% 
CI 0.72-4.74, p=0.20). Poole estimates from 
two studies moderate vs liberal control did no 
show a relationship between atrial fibrillation, 
glycaemic control was not significant (odds 
ratio 0.54 95%CI 0.17-1.76, p=0.31). 3 studies 
that compared strict vs moderate glycaemic 
control also did not find a significant difference 
on incidence on atrial fibrillation (odds ratio 
0.71, 95% CI 0.39-1.30, p=0.27). 
Relationship between glycaemic control wound 
infection was not a significant throughout, odds 
ratio was 0.25 (95% CI 0.01-5.20, p=0.37) for 
the moderate vs liberal control from 2 studies 
and 0.52 (95% CI 0.01-31.1, p=0.75) for the 
strict vs moderate from three studies. 
5. Peri operative 
management 
of patients 
with diabetes 
undergoing 
ambulatory 
elective surgery 
Coan, KE., 
Schlinkert A.B., 
Brandon .R.B., 
Haakinson 
D.J Castro J.C 
Schlinkert , R.T and 
Cook, C.B 
2013 Retrospective 
study. A review 
of medical 
records. 
268 patients who 
had type 2 diabetes. 
Mean ages were 67. 
Most were obese. 
Had been diagnosed 
with diabetes. Used 
different regimes for 
glycaemic control 
pre-op. Adult 
patients. 
USA? 
American 
hospital – not 
well described 
268 patients who underwent 287 elective 
procedures 17 patients had two procedures? 
what for. 1 patient had 3. 
Pre-op evaluations were conducted in 192/68%. 
Hba1c was obtained in only 52% n=149 36%of 
values were 7.0%. and 21 (14%) were 8.0%. 
patients taking oral medication plus insulin had 
a significantly higher HbA1C versus patients 
on diet therapy alone, oral agents or insulin, 
alone. No differences in HbA1c among the 
latter mentioned patients. Most cases had an 
American societies of anaesthesiologist’s 
physical status of 3. After 219 of 217 / 76% 
surgical procedures patients required admission. 
Mean pre-operative HbA1c was 7.0%however 
this was only obtained in 52% of the 287 cases 
with the average interval 18 days prior to 
surgery. 
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6. Preoperative 
A1C and 
clinical 
outcomes 
in patients 
with diabetes 
undergoing 
major non 
cardiac 
procedures.  
Underwood, P., 
Askari,R.,Hurwitz, 
S., Chamarthi, B 
and Garg, R. 
2014 Retrospective 
study. Data 
was obtained 
from the 
national 
surgical quality 
improvement 
group NSQIP. 
Which 
included 
preoperative, 
intraoperative 
and 
postoperative 
variables in 
randomly 
selected same 
of patients 
(20% of all 
surgery in 
the institute).   
compared 
outcomes in 
five categories: 
heathy 
individuals, 
diabetes with 
A1C >6.5-8%, 
diabetes with 
A1C> 8-10% 
and diabetes 
with A1C 
>10%. 
2,395 surgeries 
performed on 
1775 patients 
with diabetes. 
Adult patients 
undergoing general, 
gastrointestinal, 
endocrine, thoracic, 
oncologic and 
vascular surgery. 
Diabetes patients 
with an A1C 90 
days before surgery 
were included. A 
non-diabetes control 
group admitted to 
the hospital during 
the same time 
period and matched 
for age (± years 
in the following 
groups; 18-24, 25-
34, 35-44, 45-54,55-
64,65-74 and 7, sex, 
BMI (<18, ≥18 and 
<25, ≥25-30, and 
>30kg/m2. 
Brigham 
women’s 
institute 
Boston 
Massachusetts, 
USA. 
LOS was a primary outcome. 622 (35%) of 
patients had a A1C available 90days before 
surgery. Distribution of patients with missing 
A1C was equal across the racial groups. 
Among Caucasians 73% had missing A1C 
values. 449 were included in the final analysis. 
Patients with diabetes were more likely to be 
non-white smokers who underwent vascular 
surgery more often than subjects in the control 
group. Patients with diabetes has significantly 
higher surgical complications such as death, 
infections and LOS. Patients with diabetes had 
a significantly higher hospital stay (p<0.0001) 
even after adjustments for age, sex, BMI, race, 
smoking status, type of surgery (vascular vs 
general). CCI and glucose level on the day of 
surgery. 
A1c levels >6.5-8% had LOS similar to 
the control group (p=0.5).  however LOS 
in patients with A1C levels ≤6.5%, A1C> 
8-10% and A1C > 10% was significantly 
longer compared with the  control subjects 
(p<0.001,p<0.008, and p=0.002, respectively 
).compared with individuals with A1C levels 
≤6.5 and > 8% (combined group of A1C 
>8-10% and A1C > 10%) were associated 
with significantly longer LOS compared with 
control subjects in the A1C group > 6.5-8 % 
after accounting or multiple testing. There were 
no significant different among other surgical 
outcomes- 5 previously mentioned criteria. 
After removing high risk individuals with A1C 
levels ≤6.5%, univariate regression analysis 
demonstrates that higher A1C values in patients 
with diabetes are associated with increased 
LOS.  This relationship remained significant 
even after removing adjustments for other 
previously mentions patient characteristics, 
which remained significant even after removing 
patients who died during the hospitalisation 
period. 
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7. Perioperative 
diabetes care: 
development 
and validation 
of quality 
indicators 
throughout the 
entire hospital 
pathway
Hommel  , I ., Van 
Gurp, P.J., Tack, 
C.J., Wollersheim, 
H and  Hulscher, M 
E.J.L . 
2015 Literature-
based modified 
Delphi 
method . A 
set of quality 
indicators 
were created 
to assess 
peri-operative 
diabetes care.  
A practice test took 
place in 6 Dutch 
hospitals using a 
sample of 389 major 
surgery patients 
with diabetes who 
had undergone 
abdominal (32%), 
cardiac (29%)
or large joint 
orthopaedic surgery 
(39%).  62% of 
these patients were 
women, 38% men.  
The panel creating 
the quality indictors 
were 35 experts 
on peri-operative 
diabetes care 6 
anaesthesiologists/ 
internists with an 
interest in diabetes 
care, 5 ITU 
specialists, and 4 
surgeons.  
6 Dutch 
hospitals 
Netherlands 
between may 
2009 and 
November 
2009. 
Likert rating scale ranging from 1- 9, not 
relevant - relevant. An answer of cannot 
assess was made available. An indicator was 
considered unmeasurable if > 25% of patents 
individual l indicators score could not be 
computed because of missing data. Quality 
indicators were selected according to their 
relevance , median scores of 7,8 and 9 if there 
was no disagreement 30%or more ratings in 
both the 1-3 and 7-9 tertiles. 
1100 patients with diabetes who underwent 
major surgery were identified. Practice test was 
under taken with the finial 36 quality indicators 
on a sample of 389 patients. 
Clinometric properties for the outcome’s 
indicators Please see table 1 and 2 in study. 
Measurability -  >25% of scores were missing 
at he time of data extraction.
Applicability
As hypoglycaemia rarely occurred, the 
indicator intravenous glucose ordered for 
pasting patients was inapplicable. 
Reliability The indicators blood glucose 
measurement every 4-6 ours ordered for fasting 
patients had a kappa of 5.1, which indicted 
moderate interobserver reliability. In other 
indicators kappa scores of >0.6 considered. 
Improvement potential the potential for 
improvement as low for four process indicators 
and one outcome indicator. 
Case-mix stability was assess for 12 indicators 
that had good climetric properties (1, 4, 8, 9, 
11, 15, 16, 18, 21-23, 26) . All these needed 
correction for case-mix. The indicators blood 
glucose every 2 hours during surgery was 
influenced by gender. 
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8. Peri-operative 
diabetes care: 
room for 
improving 
person 
centredness. 
Hommel, I., Van 
Gurp, P.J., tack, 
C.J., Liefers, 
J. .,Mulder , J., 
Wollersheim, H. and 
Hulscher , M.E.J.L.
2014 Survey. Survey 
related to 7 
dimensions 
of person 
centeredness in 
diabetes care 
Information, 
patient 
involvement, 
communication 
and education, 
coordination, 
access to care, 
transition, 
physical 
comfort and 
continuity. 
298 out of 690 
participants with 
diabetes who 
underwent major 
abdominal, cardiac 
or large –joint 
orthopaedic surgery. 
Adult patients. Male 
female split not 
stated. Ethnicity 
of participants not 
mentioned. 
6 Dutch 
hospitals, 
Netherlands 
Complete data was 298 of 690 participants. 362 
returned a completed questionnaire. 24 did not 
completed an informed consent form and were 
therefore excluded. 17 medical records showed 
that criteria were not met and were excluded. 
23 were excluded because full data was not 
available. 
65% of participants had reported care as 
described for each item. 
The scores form the dimensions ‘access to care’ 
varied from 52% to 92%. 52% of participants 
had the opportunity to contact his/her internist. 
Overall scores for ‘information’ were 
low- 13 of 16 items had scores of below 
65%. Preoperatively few patients received 
information 31% and information about target 
BG. Post operatively few patients were told 
about their intraoperative BG and insulin 
administered 20% and 15%. 
Patient involvement was also low. 7 of 11 
scores were less than 65%.
Scores for communication and education were 
higher than 85%. 
Physical comfort had scores under and over 
65%. 
Overall scores for co-ordination and integration 
of care were low. 5 out of 8 items had scores 
below 65%. 13% did not know who their 
caregiver was in charge of their diabetes 
treatment. Or who to contact during their stay 
17%. 
Transition and continuity varied from 42% to 
92%. 49% indicated their G.P knew about their 
diabetes treatment when they were discharged.
Variation between hospitals was not significant 
a range of less than 20% was noted.
Insulin treatment prior to hospital admission 
was associated with higher mean scores for the 
dimensions of patient’s involvement (p<0.001) 
and co-ordination (p<0.005). Older participants 
had lower mean scores for the dimensions 
of information (p=0.002) and co-ordination 
(p=0.012).  these patients who were also treated 
with oral hypoglycaemic agents or diet prior 
to hospital admission had the lowest scores for 
information (p=0.023). 
Longer hospital stay was associated with higher 
scores for coordination (p=0.003).
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9. Peri-operative 
hyper glycemia 
and risk of 
adverse events 
among patients 
with and 
without diabetes 
Kotgal, M ., 
Symods, RG , 
Hirsch, lrl, B , 
Guillermo.E., 
Umpierrez.,Patchen 
Dellinger , E., 
Farrokhi, E.t., Flum. 
D.R.  
2015 Cohort study 
2010-2012  
40,836 patients 
with a mean age 
of 54 years. 53.6% 
females. 19% had 
diabetes. Adult 
patients. 
53 hospitals 
in Washington 
state USA 
19% of the cohort had diabetes :47% underwent 
peri-operative blood glucose test. Of those with 
diabetes melitus (DM)18% had perioperative 
hyperglycaemia 40% of DM patients and 
6% of NDM. 18% had a BG of 180mgdl 
and above. Diabetes patients had a higher 
rate of events 12% compared to those non 
diabetes melitus patients (NDM). NDM those 
with hyperglycaemia had an increased risk 
of adverse events compared with those who 
has a normal BG. There was a dose response 
relationship found with B.G and adverse events. 
NDM were less likely to receive insulin at each 
level p<0.001.
All patients who had peri-operative 
hyperglycaemia and received insulin, those who 
had persistent hyperglycaemia had significantly 
higher adverse event rates than those whose BG 
was corrected 40.3%vs 25.6% for NDM 17.5% 
vs 8.3% for DM patients. 
DM patients had a higher composite adverse 
event rate than NDM. 12.0%vs 8.9%, 
p<0.0001. 
Patients who underwent BG testing had no 
difference in the rate of adverse events between 
DM and NDM 12.6%VS 12.1% p+0.26. 
Those with adverse events of hyperglycaemia 
DM Patients did not have increased odd of 
adverse vents odds ratio OR =0.76% (95% 
confidence interval, CI) 0.57-1.0,p+0.06) for 
BG 125mg/dl and or =0.94(95% CI 0.72-1.2 
;=0.65) FOR BG >_ 180mg/dL in an unadjusted 
analysis . DM patients with BG between 125 
and 180 mg/dL were found to have decreased 
odds of adverse event (OR =0.66 (95% CI = 
49-0.91) when compared with the reference 
group. BG <_BG<125mg/dl. Patients with 
a BG level more than 180mg/dL, had no 
significant difference in odds of adverse 
event (OR =0.78(95%CI =0.58-104) whence 
compared with the reference group. 
NDM patients with hyperglycaemia had 
significant higher odds of a composite adverse 
event (OR =2.4(95% CI, 1,9-3.0) for BG 
125-180 mg/dL OR = 5.1 (95% CI, 3.8-6.9) 
for BG >_180mg/dL; p<0.001 for both. 
If hyperglycaemia persisted, with a. dose 
response relationship between the level of 
hyperglycaemia and the odds o a composite 
adverse event (OR =1.26(95%CI. 1.08-1.47 for 
BG 125- 180mg/dL.  
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10. Perioperative 
management 
of diabetes 
in elective 
patients: a 
region-wide 
audit.
Jackson, M.J ., 
Patvardhan, C., 
Wallace, F., Martin, 
A., Yusuff, H., 
Briggs, G and Mailk 
, R.A. 
2015 Region wide 
audit of 
adherence 
guidance 
across the 
north west of 
England. 
247 patients with 
diabetes. Adult 
patients. Elective 
surgery patients 
only. No Pregnant 
patients. Mean ages 
was 56.8 (00.00)
yrs. ASA grades 
(41%ASA II, 5.8% 
ASA III). 
North West of 
England. 
HbA1c was recorded in 71% of patients 
preoperatively 168/238. 87% (214/247) were 
seen in a preoperative assessment clinic. 
The mean HbA1c was 50.8 (16.9) mmol. 7.5 
(3.7%). 20% (34/168) of patients who had 
their HbA1c greater than 69mmol (8.5%) these 
operations continued as planned.23% (52/230) 
were under the care of the diabetes specialist 
team. 14/164 had a HbA1c > 69mmol/l. 8.5% 
were not under specialist diabetes care.
9% of patients with abnormal HbA1c were 
not known by or referred to by the diabetes 
team. 17% (42/243) of patients were admitted 
the evening prior to surgery for glycaemic 
control. They tended to have higher pre-
operative HbA1c. [71.6 (13.7)]mmol.mol . 
[8.7(3.4%)] compared with 58.0 (16.9)mmol.
mol 7.5 (3.7%). Pre anaesthesia CBG was in 
an acceptable range for 75% of those patients. 
CBG measurement was performed before 
induction in 93% (22/243) patients. CBG was 
in the acceptable range of (4 to 12 mmol) in 
89% (201) and 61% (137). 3 patients had a CB 
> 4mmol. 22 had a CB <12mmol (mean 13.7 
mmol, range 12.1mmol -16.9mmol).
Mean fasting time for patients was 12:20(4) h. 
data was only available in 222 of these patients. 
51% (124/244) were first on the list.
Variable rate I.V insulin infusions (VRIII) 
were not indicated in 11%. 8% of patients 
received the recommend substrate fluid along 
with VR (5% glucose and 0.45% saline) 
Intraoperative CBG was measured hourly 
in 56%. Intraoperative CBG was within an 
acceptable range (4-12mmol/l) in 85% of 
patients. A VRIII was used in 39 patients; 27 
who had short starvation period. A VRIII was 
not used in 25 patients missing two or more 
meals.; 4 ,13, and 8 of these patients routinely 
use insulin. Only the recommended VRIII 
was used in 3/39. Median operation length 
was 1:15 h intra-operative CBG was only 
available in 105/247 (43%). During operation 
50% of patients 53?105 where within the ideal 
range. 85% (89/105) were in acceptable range. 
Lowest record CBG was 2.7mmol. highest was 
20.1mmol. 
73%of patients had CBG performed in the 
recovery room WHO checklist was used in 
95% of patients. 
91% 150\165 were in the acceptable range, 
55% in the ideal range (91/165) values ranged 
from 2.4mmol-213mmol/l. 57% (135/238) 
eating one-hour post-surgery and 36% planning 
the next meal (86/238). &% did not exact the 
next meal due to surgical decision or POMV. 
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11. Postoperative 
adverse events 
in patients 
with diabetes 
undergoing 
orthopaedic and 
general surgery
Wang, J., Chen, 
K., Li, X., Jin, X., 
An, P., Fang, Y and 
Mu, Y. 
2019 Single centre 
retrospective 
study of 
adverse events 
using patient 
medical 
records. 
Analysed using 
multivariable 
logistic 
regression.   
1525 Patients 
diagnosed with 
type 1 or type 2 
diabetes prior to 
surgery. Patient 
underwent general 
and orthopaedic 
surgery 8.8 ±6.6 
years. Mean BMI 
of 25.8 ±3.9kg/m2. 
Males 779 (51.1%) 
and 746 (48.9%). 
Mean ages was 63.5 
± 10.8 years. 
Bejing – the 
general 
hospital 
of people 
liberation 
Army. 
Patient’s baseline was obtained from the 
hospital medical records such as age, sex, BMI 
dieses course, diabetes complications, diabetes 
co-morbidities. Pre- and post-nutritional 
support, biochemical indices, venous blood 
glucose levels and peripheral blood glucose 
levels.  
Of the 301 (19.8%) of all patients with diabetes 
complications, 295, (98.0%) had major 
vascular complications, 8 (27. %) had diabetes 
nephropathy, 3 (0.7%) had diabetes retinopathy, 
5 (1.7%) had diabetes foot. Of the 1019 
(66.8%) patients with diabetes comorbidities 
758 (49.7%) had hypertension, 183, (12.0%) 
had coronary heart disease. 94 (6.2%) had 
cerebrovascular disease.
761 (49.9%) and 764 (50.1%) underwent 
general surgery.  mean hospital stay was 
14.7±12.1 days.
Post-operative adverse events occurred in 118 
(7.7%) including 43 (36.4%) delayed estuation 
cause by surgery-related respiratory failure and 
or respiratory muscle weakness. 15 (12.7%) 
patients with circulatory disorders, 23 (19.5%) 
had respiratory and circulatory abnormalities. 
11 (9.3%) had nonhealing of the incision. 
15 (12.7%) had infections at other sites. 8 
(6.8%) patients with other complications (1 
case); adhesive intestinal obstruction, renal 
failure, case, disturbance of consciousness, 
persistent anatomical bleeding, metabolic 
acidosis, digestive tract haemorrhage, multiple 
compound injury. 3 (2.5%) patients who 
died, including pulmonary embolism, and 
two cases of septic shock. Seven factors were 
significantly different between groups with and 
without adverse events.  age > 65 years [OR = 
2.03, 95% confidence interval (CI): 1.76-3.77, 
p<00.1], sex (OR=20.3, 95% CI 1.39-2.97, 
p<00.01), systolic blood pressure, >140 
mmHg (OR =1.64, 95% CI 1.14-2.35, p=.007), 
smoking (OR =1.68, 95%CI: 1.11-2.55, 
p+.015), postoperative mean peripheral blood 
glucose (OR1.13 per 1mmol/L, 95% CI:1.03-
1.24, p=.009), diabetes comorbidities (OR 
=2.32, 95% CI: 1.44-37.3, p<.001), abnormal 
kidney function (OR=27.3, 95% CI:1.66-6.69, 
p=.001) and general surgery (OR = 1.69, 
95%CI:1.32-5.67, p=.013). 
Multivariable analysis, in various tables, table 
3 and figure 2. Ages >65 years (OR=2.2395% 
CI: 1.25-3.98, p=.002), postoperative mean 
peripheral blood glucose, (OR =1.13 per 
1mmol/L, 95% CI:1.13-1.82, p=.029), diabetes 
complications (OR=2.41, 95% CI:1.36-4.28, 
p=0.003), abnormal kidney function, (OR 
=2.73, 95%CI: 1.13-6.58, p=.003), general 
surgery (OR =1.48, 95% CI: 1.11-5.26, P=.023) 
in relation to post op adverse events.
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